Drug intelligence / Profile preview

Geng-Nian-Zi-Shen

Development stage: Preclinical
Lead developer: Guangzhou University of Chinese Medicine
Administration: Oral

Overview

Geng-Nian-Zi-Shen is a Traditional Chinese Medicine (TCM) oral solution currently under investigation for its efficacy in improving hypoestrogenemia, particularly in patients who have undergone endometriosis surgery. Developed by institutions such as Guangzhou University of Chinese Medicine, it is believed to exert its therapeutic effects through the TCM principle of nourishing Kidney Yin, which is associated with balancing reproductive and endocrine functions. As a multi-ingredient herbal preparation, its precise Western pharmacological mechanisms are not fully elucidated, but its clinical application targets symptoms related to estrogen deficiency.

Other names: Geng-nian-zi-shen oral solution更年滋肾口服液

Beyond the preview

Go deeper on Geng-Nian-Zi-Shen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Geng-Nian-Zi-Shen.

Explore the full profile